Skip to content

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies.Continue

Eli Lilly and Company Limited

Humalog 200 Units/ml KwikPen, solution for injection in pre-filled pen

Certain risk materials on this website are intended for use by healthcare professionals only.

By proceeding you are confirming that you are a healthcare professional.

CANCEL PROCEED

You can leave feedback on specific Risk Minimisation Materials or make general observations about how they are displayed on the eMC by leaving comments in the box below.

Please note that we are unable to respond to medical queries.

Humalog 200 Units/ml KwikPen, solution for injection in pre-filled pen


Please enter your email address below

Tick here if you wish to recieve a response to your feedback

Risk Materials
VIEW

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

Humalog 200 Units/ml KwikPen (insulin lispro) important safety information for patients

CLOSE THIS PANEL
View Patient Information Leaflet

The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine. It is written for patients and gives information about taking or using a medicine.

This PIL is in PDF format and so you must have a PDF reader installed on your device to read it.

Company Information

Eli Lilly and Company Limited

http://www.lilly.co.uk

Address : Lilly House, Priestley Road, Basingstoke, Hampshire, RG24 9NL

Telephone : +44 (0)1256 315 000

Fax : +44 (0)1256 775 858

Medical Information e-mail :

Medical Information Fax : +44 (0)1256 775 569

More information about this medicine

Legal categories

  • POM

Active ingredients/generics

  • insulin lispro

Summaries of Product Characteristics (SPCs):

© 2017 Datapharm Communications Ltd